Updates

CSRxP Praises FDA For Finalizing Guidance On Interchangeable Biologics

May 10, 2019

Clearer Guidelines Will Increase Choice and Help Lower Prices Washington Read More

THEY SAID IT! House Energy & Commerce Lawmakers Roast Big Pharma, Pledge Bipartisan Action and Question the Rebate Rule

May 10, 2019

Washington, D.C. – The House Energy & Commerce Subcommittee on Health Read More

CSRxP: Congress Takes First Step On Drug Pricing, Now Lawmakers Must Deliver

May 8, 2019

Encourages House Leaders To Keep The Momentum Going Following Passage Of First Read More

CSRxP Urges House Lawmakers to Pass First Drug Pricing Bills of the Year

May 8, 2019

Vote On Orange And Purple Book Bills Should Mark Beginning Of A Series Of Read More

CSRxP Praises Administration For Implementing Direct-To-Consumer Advertising Rule

May 8, 2019

Greater List Price Transparency Will Help Hold Big Pharma Accountable  Read More

CSRxP: Senate Judiciary Lawmakers Grill Big Pharma, Demonstrate Bipartisan Commitment To Action

May 7, 2019

Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today Read More

CSRxP Welcomes Senate Scrutiny Of Big Pharma’s Patent Abuse

May 6, 2019

Encourages Judiciary Committee To Hold Drug Makers Accountable Read More

CBO Confirms: Rebate Rule Comes At Tremendous Cost to Seniors And Taxpayers

May 2, 2019

Nonpartisan Analysis Projects HHS Proposal A $187 Billion Budget-Buster That Read More

Q1 Earnings Show Big Pharma Booming While American Patients Struggle

May 1, 2019

Largest Drug Makers Beat Profit Forecasts While Continuing To Price Gouge Read More

Big Pharma Earnings Watch

May 1, 2019

GSK Completes The Sweep: Joins Fellow Drug Maker Giants In Beating Q1 Profit Read More

Q1 EARNINGS SHOW BIG PHARMA BOOMING WHILE AMERICAN PATIENTS STRUGGLE

May 1, 2019

Largest Drug Makers Beat Profit Forecasts While Continuing To Price Gouge Read More

Big Pharma Earnings Watch: Three More Pharma Giants Top Earnings Forecasts, Raise Outlooks

Apr 30, 2019

Three more earnings reports from drug makers show Big Pharma is doing just Read More